BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Clinical trial NCT05161429 · UNKNOWN

Trial details

NCT number: NCT05161429
Sponsor: Brigham and Women's Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2021-07-01
Primary completion: 2024-06-30
Enrollment: 550000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.